Posts Tagged: Omar Khan
Dr. Omar Khan is one of four researchers are the latest to receive support to spin-off aspects of their Medicine by Design-funded research into an early-stage product or venture as part of Medicine by Design’s Pivotal Experiment Fund, which has distributed more than $2.5-million in funding since its launch in early 2021.
Azane Therapeutics, made up of members from the Omar F. Khan lab, was the second-place team at the Building a Biotech Venture Pitch Competition.
Omar F. Khan was first inspired to be an engineer by his father's workplace accident. Now, his lab is studying nanomaterials & pushing the boundaries of regenerative medicine.
Dr. Omar Khan's lab is creating new nanotechnologies to control and deliver nucleic acids, will lead a team that plans on working with Moderna to develop next-generation vaccine platforms.
Penney Gilbert, Milica Radisic, and Omar Khan are three BME faculty members among seven FASE faculty members who have earned new or renewed Canada Research Chairs.
Dr. Omar Khan comments on the recent news on Omicron variant.
Dr. Omar Khan discuses Delta variant concerns being raised as Canada with Sonia Deol on Global News.
Dr. Omar Khan and George Lagogianes discussing the merits & concerns of vaccine passports, why 2 doses matter, & why Canada's policies are inevitably tied to the global COVID-19 situation.
Breakfast Television: Dr. Omar Khan, a professor of biomedical engineering, to talk about the province expanding vaccine eligibility to all adults.
As Canada races to vaccinate its citizens amid an increase in variant infections, writer Liz Do spoke to Professor Omar F. Khan (BME), an immunoengineering expert. Khan, whose lab designs nanotechnology devices that can deliver RNA technology to cells for better disease treatment, explains common concerns and questions around COVID-19 vaccines.
Showing 11 - 20 of 23 results